We determined the plasma kinetics of both actin and complexes of actin with the two high affinity actin-binding proteins of plasma, gelsolin, and vitamin D-binding protein (DBP). Actin is cleared rapidly from the plasma by the liver (half-disappearance time, 0.5 h). Using radiolabeled actin-binding proteins, we found that actin accelerated the clearance of both plasma gelsolin and the vitamin D-binding protein.
Introduction
Actin is the most abundant protein found in mammalian cells, comprising up to 10-20% of many nucleated cells and 60% of the protein of muscle cells (1) . Therefore we can surmise that cell death, whether physiologic or pathologic in origin, might cause actin to appear in significant amounts outside of the cell. There it could interact with extracellular proteins, such as two high affinity actin-binding proteins that exist in plasma, plasma gelsolin, also called brevin, or actin depolymerizing factor (2) (3) (4) (5) , and the vitamin D-binding protein (DBP) ,' also called Gc globulin (6, 7) .
Using DNase-Sepharose, Thorstensson et al. adsorbed a 42,000-D polypeptide from normal serum that cross-reacted with an antiactin antibody (8) , suggesting that actin may be found in the blood of healthy subjects. On the other hand, Emerson and colleagues have presented immunochemical evidence that actin-DBP complexes can be found in the serum of pregnant women (9) or patients with acute hepatic necrosis (10) , but not in the serum of healthy humans. Thus, it is not clear if actin is found in normal serum. Further evidence, albeit indirect, speaking for the presence of actin in extracellular fluid is found in reports of patients who have antiactin antibodies in their blood (11, 12) .
Since there is evidence that actin may be released into the extracellular space, we have studied the kinetics of clearance of actin from the circulation. In so doing, it was necessary to examine the effect of actin upon the plasma kinetics of DBP and plasma gelsolin. Although the plasma kinetics ofDBP are known (13) , such information is not available for plasma gelsolin. It was therefore necessary to establish the kinetics of plasma gelsolin. We then examined the effects of actin upon the clearance ofplasma gelsolin and DBP. Finally, we examined the interaction between actin and fibronectin in vitro to clarify fibronectin's role in clearing actin from the circulation.
Methods

Materials
Enzymobeads were obtained from Bio-Rad Laboratories, Richmond, CA; '25l from New England Nuclear, Boston, MA; Iodogen from the Pierce Chemical Company, Rockford, IL; and chemicals from Sigma Chemical Co., St. Louis, MO . Reagents for preparing the tyraminecellobiose (TC) conjugates were generous gifts ofDr. Ray Pittman, University of California at San Diego, San Diego, California.
Protein preparation Plasma gelsolin was isolated from human and rabbit plasma as previously described (14) . DBP was isolated from rabbit plasma by the method of Haddad et al. (15) after an initial purification step in which 200 ml of plasma was passed over a 10-ml column of Sepharose 4B conjugated to a monoclonal antigelsolin antibody (16) (3 mg antibody/ml of gel) to remove plasma gelsolin. Fibronectin was purified by the method of Vuento and Vaheri (17) using a gelatin-Sepharose column. The fibronectin was eluted from the column with 1 M arginine, pH 5.5. Rabbit skeletal muscle actin was purified by the method of Spudich and Watt (18) and stored as G-actin in buffer A (2 mM Tris, 0.2 mM CaCl2, 0.2 mM ATP, and 0.1 mM mercaptoethanol, pH 7.6). F-actin was prepared by the addition ofKCI and Mg2e to final concentrations of 100 mM and 2 mM, respectively. 100-,gg aliquots of plasma gelsolin, fibronectin, DBP, and actin were labeled with 125I by lactoperoxidase-coated beads (Enzymobeads) following the manufacturer's specifications. Before iodination, actin was dialyzed against buffer A minus mercaptoethanol. After iodination, the reaction mixture was passed over a Sephadex G-25 column equilibrated with a solution containing either 150 mM NaCl, 10 mM phosphatebuffered saline, pH 7.4 (PBS), and 1 mg/ml bovine serum albumin (BSA) (for plasma gelsolin, DBP, and fibronectin) or buffer A with 1 mg/ml BSA (for actin). The adequacy of this separation was assessed by precipitating the labeled protein (10 1d) with 1 ml of ice-cold 10% TCA in the presence of 50 ;d of carrier serum. Fractions that were >90% TCAprecipitable were used for the experiments described. The radiolabeled proteins were subjected to electrophoresis in 5-15% polyacrylamide gels
In addition, the ability of radiolabeled gelsolin to nucleate actin filament assembly was determined. Radiolabeled gelsolin was incubated with actin, labeled with N4l-pyrenyl)iodoacetamide (pyrene-actin) by the method of Kouyama and Mihashi (19) in buffer A, as previously described (5) , before the addition of MgCI2 and KC1 (final concentrations of2 and 100 mM, respectively). The fluorescence ofpyrene-labeled actin increased in solutions containing labeled gelsolin at 95% of the rate of solutions containing unlabeled gelsolin (Fig. 1) , indicating that the labeled gelsolin had retained its function. Previous experiments employing gel filtration chromatography showed that the radiolabeled gelsolin eluted as a single species (20) .
Human plasma gelsolin and rabbit skeletal muscle actin were labeled with a TC adduct by the method ofPittman et al. (21, 22) . In this method the TC adduct is prepared by reductive amination to form a compound that is not hydrolyzed in cells, thus preventing reutilization of the label and indicating the final degradation site ofthe labeled protein. The adduct was iodinated using the Iodogen method before being added to a crosslinking reagent, cyanuric chloride, which coupled the adduct to the protein. The activated ligand (46 Mg) was added to 330 1Ag ofgelsolin or 900 ,ug of actin and allowed to react for 75 min at room temperature. The labeled actin (TC-actin) was centrifuged at 35,000 g for 1 h at 40C, resuspended in PBS, and then dialyzed against PBS for 18 h. The labeled gelsolin (TC-gelsolin) was passed over a Sephadex G-25 column equilibrated with PBS and I mg/ml BSA and was then dialyzed against PBS for 18 h before being injected into rabbits.
Efforts were made to remove damaged radiolabeled molecules before the performance of the clearance studies. In some experiments, plasma gelsolin was screened by using one rabbit to remove damaged molecules before their injection into a second rabbit, which was then used to determine the kinetics of the protein. 10 Mg of radioactive gelsolin was injected into a healthy rabbit. 3 h later, the rabbit was anesthetized with sodium pentobarbital and bled by cardiac puncture into heparin-containing syringes. The plasma was separated, and a saturated solution of ammonium sulfate was added at 40C to yield a final concentration of 28%. After 30 min the solution was centrifuged at 12,000 g for 10 min. The resulting precipitate was discarded and the supernatant fluid made Radiolabeled actin was added to solutions containing 25 mg unlabeled actin under polymerizing conditions (2 mM MgCl2 and 100 mM KCI).
After allowing actin filaments to polymerize at 20'C for 2 h, the solution was centrifuged for 4 h at 35,000 g at 4°C. The actin filament pellet was washed and resuspended in 1 ml of PBS. It was dialyzed against PBS with frequent changes ofthe dialysate for 24 h. The solution was clarified by centrifugation at 12,000 g for 10 min at 4°C and injected into rabbits. 3 mg of actin were injected into each rabbit.
Radiolabeled DBP was passed over an actin affinity column as described for the purification of the protein. The labeled DBP was eluted with 0.25 M glycine, pH 2.75. The pH was brought to 7.0 by adding NaOH, and the protein was dialyzed overnight at 4°C against PBS, after which time it was injected into rabbits.
Radiolabeled fibronectin was added to 0.5 ml of human serum and then passed over a 2.5-ml gelatin-Sepharose column. After washing the column, the labeled fibronectin was eluted with I M arginine, pH 5.5, and dialyzed into a buffer containing 50 mM Tris, 100 mM NaCG, pH 7.4.
25I-actin-DBP complexes were prepared by mixing equimolar amounts of DBP (in PBS) and labeled actin (in buffer A). The final actin concentration was 20 MM in 2 ml. The complexes were allowed to form at room temperature for 60 min before being injected into rabbits. 0.5 Mg of actin was injected into each rabbit.
251I-actin-gelsolin complexes were formed by mixing radiolabeled actin (in buffer A with 2 mM MgCl2 and 100 mM KCG) with plasma gelsolin (in PBS) at an actin/gelsolin molar ratio of 2:1 (final actin concentration, 20 MM). The mixtures were incubated for 60 min at room temperature. Since DBP removes one actin molecule from a 2:1 actin/ gelsolin complex (23), we incubated these complexes with DBP-Sepharose to make 1:1 actin/gelsolin complexes. The 2:1 complexes, in 1.2 ml, were added to 2 ml of DBP-Sepharose beads (1 mg DBP/ml of Sepharose 4B) and rotated end-over-end for 1 h at room temperature. The mixture was centrifuged for 12,000 g for 5 min and the supernatant removed for injection into rabbits. Half of the actin molecules were removed from each 2:1 complex, as verified by counting the DBP-Sepharose beads, thereby producing 1:1 actin/gelsolin complexes.
Actin filaments that contained gelsolin at their fast-growing ends (gelsolin-actin complexes) were prepared by adding '25I-labeled human plasma gelsolin (7 Mg) to a solution containing G-actin (5 mg) in the presence of 100 mM KCI and 2 mM MgC2. Polymerization was allowed to proceed for I h at 20°C. 1 M MgCl2 was then added to a final concentration of 0.05 M, which caused actin paracrystals to form (24). The paracrystals were collected by centrifugation at 45,000 g for 3 h at 4°C.
They were dialyzed against 4 liters of PBS with 2 mM MgCl2 and 1 mM CaCl2 overnight, which solubilized the parystals. Magnesium-induced actin paracrystals were prepared as a way of separating gelsolin-actin complexes from nonfunctional gelsolin molecules. The precipitation of Plasma Actin Clearance magnesium-induced actin paracrystals was undertaken to insure that only actin-binding molecules would be collected. The use ofparacrystals rather than dispersed actin filaments increased the efficiency ofcollection, since complexes of gelsolin with short actin filaments may not pellet during centrifugation. The actin-gelsolin complexes were then injected into rabbits and the plasma decay curves determined as described below.
The following experiment was performed to show that gelsolin was not damaged by the magnesium, and that gelsolin-actin complexes are stable in 50 mM Mg2e. Human plasma gelsolin (I mg/ml) was added to either buffer B or buffer B with F-actin (2 mg/ml). After incubation for 10 min at room temperature MgCI2 was added to a final concentration of 50 mM. After further incubation at room temperature for I h, the solutions were dialyzed overnight at 4VC against buffer B, and were then analyzed for functional gelsolin activity. Both the treated gelsolin and gelsolin-actin solutions nucleated actin filament assembly at the same rate as the untreated gelsolin. The treated gelsolin also severed actin filaments in an identical manner to the untreated gelsolin. The solution containing both actin and gelsolin did not sever actin filaments. Since gelsolin-actin complexes nucleate filament assembly but do not cut filaments, these findings indicate both that gelsolin retains its function and that gelsolin-actin complexes are present after exposure to 50 mM Mg2+.
Fibronectin-binding experiments
Radiolabeled fibronectin was incubated with F-actin in buffer A with 2 mM MgCl2 and 100 mM KCI for 60 min at room temperature. The solutions were then centrifuged at 160,000 g for 60 min at room temperature in an airfuge. The supernatant was separated from the pellet. I00 ul of the supernatant was taken for counting in a gamma counter. The pellet was washed once with polymerizing buffer and then counted.
Effect offibronectin on actin polymerization
Fibronectin was added to pyrene-labeled G-actin and the polymerization of actin was monitored by a change in the fluorescence of the actin as previously described (5).
Measurements ofplasma gelsolin levels
Levels of plasma gelsolin in humans and rabbits were measured by a functional assay that measures the ability of plasma gelsolin to nucleate actin filament assembly in a concentration-dependent fashion in the presence of calcium (Smith, D. B., P. A. Janmey, T. J. Herbert, and S. E. Lind, manuscript submitted for publication).
Animal experiments Kinetic studies. New Zealand White rabbits (3.0-3.5 kg) were given free access to drinking water containing 0.02% Nal. Before the injection of radiolabeled proteins, 1 ml of blood was drawn for measurement of baseline plasma gelsolin levels. The rabbits were injected with labeled proteins in I ml of PBS via a marginal ear vein and were bled from the opposite ear.
10 min after the protein was injected, 1 ml ofblood was drawn from the contralateral ear into a syringe containing 10 ,d of heparin (10 U), and the plasma separated. 0.4 ml of plasma was added to 2 ml of icecold 10% TCA and the radioactivity in the precipitates that formed was determined in a gamma counter. Blood samples were obtained at intervals thereafter and the plasma level ofTCA-precipitable radioactivity at each time expressed as a percent ofthe counts present in the 10-min sample.
Organ clearance distribution studies. Rabbits were injected with TCgelsolin (50 gg) or TC-actin (425 ,ug) and blood was drawn for the determination ofTCA-precipitable counts in the plasma as described above. At the indicated times, the animals were killed by intravenous injection of 350 mg of sodium pentobarbital. The viscera were removed, washed in saline, blotted dry, and weighed. Samples of the organs (-I g each) were excised, blotted dry, weighed, and counted in a gamma counter.
Data analysis. The kinetic data was analyzed by the method ofMatthews (25) . The TCA-precipitable radioactivity remaining in the plasma was plotted against time on semilogarithmic graph paper. Curve peeling was used to determine the parameters of clearance, allowing calculation of the fractional catabolic rates in the standard fashion. The synthetic rate was calculated by the formula: synthetic rate (mg/kg per h) = C X V X FCR/W where C is the plasma concentration of gelsolin (milligrams/milliliters), V the plasma volume (equal to the animals's weight in grams X 0.04, expressed in milliliters), FCR the fractional catabolic rate and W the animal's weight (kilograms).
The sites of clearance of labeled TC-gelsolin or TC-actin were determined by the method of Webster et al. (26) . The parameter R, a measure of the clearance of the protein per mass of an organ, was calculated by the formula: R = micrograms of gelsolin in the organ per gram of organ/micrograms of gelsolin injected per gram of total body weight. We developed a second parameter, R', multiplying R by the organ weight to obtain a measure of the clearance of gelsolin by each organ, a value weighted by the total mass of each organ.
Results
Kinetics ofplasma gelsolin. In some experiments, labeled human plasma gelsolin was screened in one rabbit before being injected into a second for the determination of its plasma kinetics (Fig.  2) . The half-life of the terminal phase of the decay curve was 2.3 d, similar to that found when unscreened gelsolin was injected directly. Other clearance parameters changed as a result of screening, as shown in Table I . Almost 50% of the total plasma gelsolin is extravascular.
Similar studies were carried out with rabbit plasma gelsolin. Rabbits were found to have higher plasma gelsolin levels than humans (mean of 8 rabbits = 368 ,g/ml, mean of 56 humans =211 1Ag/ml). Kinetic parameters comparable to those obtained for human plasma gelsolin were found as shown in Table I , although the fractional catabolic rate for screened rabbit plasma gelsolin was greater than that for the screened human protein (0.059%/h vs. 0.036%/h). The mean synthetic rate for plasma gelsolin for the three animals receiving rabbit plasma gelsolin was 0.65 mg/kg per h.
Sites ofclearance ofplasma gelsolin. The clearance of TCgelsolin from the plasma was comparable to unconjugated gelsolin (data not shown). Four rabbits were studied with labeled TC-gelsolin. As shown in Table II protein (including the vascular, cellular, and extracellular compartments), although the constancy of the values obtained for the solid organs suggests that the adduct has reached equilibrium with a cellular pool.
Clearance ofactinfrom the circulation. Radiolabeled F-actin was injected into rabbits and the clearance of radioactivity from the circulation determined, as shown in Fig. 3 . Actin was cleared from the circulation with a half-disappearance time of -30 min.
(G-actin was not injected since it rapidly binds preferentially to DBP, and would simply give a G-actin-DBP clearance curve. F-actin, on the other hand, interacts in a sequential and defined manner with both gelsolin and DBP [23] .) The clearance of the '251I-TC-actin from the circulation was similar to that seen when 251I-actin was injected (data not shown). Table III indicates that while the lung and spleen may play a role in actin clearance, the liver is the major site of clearance of I251-TC-actin. The decline in whole organ accumulation by the lung and spleen with the passage of time may be due to the fact that these data reflect labeled species in both the cellular and extracellular compartments, as discussed above. Similar results were found when the organs of animals that had received 1251. actin were excised and counted.
The effect ofactin on the clearance ofgelsolinfrom theplasma.
In order to determine whether actin affects the clearance of gelsolin, complexes of radiolabeled gelsolin and unlabeled actin were prepared in vitro and injected into rabbits. As shown in Fig. 4 , the actin-gelsolin complexes were cleared from the plasma more rapidly than either screened or unscreened gelsolin. Since magnesium-induced paracrystal formation was used to prepare these complexes, unscreened gelsolin alone was treated with magnesium in an identical manner before being injected into rabbits to control for magnesium-mediated damage to the labeled gelsolin. The clearance of the magnesium-treated gelsolin was identical to that ofunscreened gelsolin. Furthermore, magnesium treatment ofunlabeled gelsolin did not affect its activity in vitro (see Methods). Since the clearance of this preparation was not faster than the clearance of actin alone, it is unlikely that damage to the actin by magnesium was responsible for the accelerated clearance of gelsolin.
The effect ofactin on the clearance ofDBPfrom the plasma.
The'clearance of 125I-DBP-G-actin complexes formed in vitro from the circulation ofrabbits was more rapid than the clearance of uncomplexed '25I-DBP, indicating that actin also accelerates the clearance of DBP from the plasma (Fig. 5) .
Evidence that DBP mediates the clearance ofactinfrom the circulation. Having found that the clearance ofboth gelsolin and DBP was accelerated by actin, we performed a clearance study to determine which protein was likely to be responsible for the rapid clearance ofactin from the circulation. '251-actin-gelsolin and '251-actin-DBP complexes were prepared and injected into rabbits. As shown in Fig. 6 , the actin-DBP complexes were cleared more rapidly from the circulation than were the gelsolinactin complexes. Since the clearance of the gelsolin-actin complexes was slower than the clearance of the F-actin (Fig. 3) , we concluded that plasma gelsolin is probably important in shortening actin filaments in the circulation, but it is not the major plasma protein mediating the clearance of actin. Interaction ofactin withfibronectin. In the first set of experiments, fibronectin was added (1.1 M) to solutions of pyrenelabeled G-actin (7.5 In the second set of experiments, a quantitative assessment ofthe binding of fibronectin to F-actin was made. We were able to show an interaction between actin and fibronectin as reported by others, but found it to be of low affinity. The low affinity of the binding prevented us from attaining saturation and thus the z 0 I-LL Figure 4 . Accelerated clearance of gelsolin-actin complexes. Complexes of radiolabeled human plasma gelsolin and actin were injected into three rabbits and the clearance of the labeled gelsolin determined. Shown for comparison is the clearance of both screened and unscreened human plasma gelsolin. Figure 6 . Clearance of actin-containing complexes from the plasma. Radiolabeled actin was used to prepare 1:1 complexes with either DBP or plasma gelsolin. The complexes were injected into separate rabbits in order to determine which ligand had a greater effect upon the clearance of actin from the plasma. The different symbols represent separate animals studied. We estimate the affinity of the actin-fibronectin interaction to be 2.9 X IO' M (data not shown).
HOURS
Discussion
The disposition ofactin, the major protein constituent ofalmost all nucleated mammalian cells, is of physiologic importance. It is likely that actin is present, at least transiently, in the extracellular space, as are a number of other cellular proteins. We therefore defined the clearance of actin from the circulation, and its effects upon the plasma kinetics of the two major circulating actin-binding proteins, DBP and plasma gelsolin.
Since the clearance of plasma gelsolin was not previously known, we determined its plasma kinetics. We found that actin accelerated the clearance ofboth DBP and plasma gelsolin from the circulation. Comparative studies using a single preparation oflabeled actin indicated that DBP plays a more important role in clearing actin from the circulation than does plasma gelsolin.
Implicit in the plasma clearance studies is the assumption that the labeled species is not altered during the purification and labeling procedures. Frequently, a proportion of the molecules in question are damaged during preparation (27) . We found this to be the case with labeled plasma gelsolin, as evidenced by the different metabolic parameters obtained when the labeled species was screened in one animal before being administered to another (Table I) . If the screened molecule is isolated from the plasma, one risks damaging or losing a proportion of the labeled molecules. The route we followed, administering a plasma fraction that contained the labeled gelsolin, avoided this problem but resulted in the administration of unlabeled gelsolin as well. Our calculations are therefore based on the assumption that the clearance ofgelsolin is independent ofthe plasma gelsolin level. While the integrity of the labeled species circulating in the animals was not examined during the course of the experiments, we have not observed fragmentation of gelsolin, actin, or DBP in other work we have performed.
Although screening is helpful in performing metabolic studies, it is not always feasible. In such cases we used other techniques to select for functional integrity in an effort to remove damaged species. It is possible that these procedures do not select for the same molecules, a reservation that must be kept in mind in considering our results.
Because of the large amount of unlabeled gelsolin administered with the screened material, we were not able to add enough actin to saturate the mixture of labeled and unlabeled gelsolin. We therefore developed a method ofpreparing gelsolinactin complexes that allowed us to simultaneously separate functional from nonfunctional gelsolin molecules. In using actin paracrystals to concentrate gelsolin we removed those radiolabeled gelsolin molecules that were not functionally intact and able to bind to actin. Thus, we made efforts through both the preparation of paracrystals and the screening maneuvers to remove damaged gelsolin molecules. It is possible, however, that the populations removed were not identical.
Affinity chromatography may also be used to separate molecules damaged during preparation and labeling (28) , and we used this technique in the preparation ofthe labeled fibronectin and DBP. Actin molecules damaged during the labeling procedure were removed by polymerizing the functional labeled actin population with unlabeled actin, and sedimenting the polymerized actin.
Several plasma proteins other than plasma gelsolin and DBP have been reported to interact with actin, including: IgG (29), Clq (30), fibrin (31, 32) , and plasma fibronectin (33, 34) . The interaction of actin with plasma proteins other than fibrin has not been examined quantitatively, though it has been suggested that actin may interact with fibronectin at sites of tissue injury (35) .
We examined the binding offibronectin to actin, since it has been suggested that fibronectin binds weakly to actin under conditions of low ionic strength (34). We found that the affinity of fibronectin for actin was very low (-2.9 X lo-4 M). Since the affinity of actin for plasma gelsolin and DBP is orders of magnitude greater, we conclude that actin will not bind to fibronectin in the circulation in the face of adequate levels of DBP and plasma gelsolin.
A number of studies suggest that actin exists in two pools within cells, present either in a monomeric or polymeric form (36) . Cell senescence or disruption of cells due to tissue injury would be expected to release both monomers (either free or bound to monomer-binding proteins, such as profilin) and filaments into the extracellular space. Since the ionic conditions needed to maintain actin filaments are present in plasma, actin filaments would be stable in plasma, and free monomers would be expected to polymerize or add to preexisting filament ends.
Several factors might work against the accumulation oflong actin filaments in the vascular space: (a) shear forces present in the circulation; (b) dilution of the actin concentration to a level below the point where there is net depolymerization offilaments (the critical monomer concentration); and (c) depolymerization of filaments by plasma proteins. The first two factors are less likely to play a role in shortening actin filaments in the extracellular space contiguous to sites of tissue injury than they are in the circulation, especially where flow is rapid and turbulent. The existence oftwo actin depolymerizing proteins in the blood, present in micromolar concentrations, suggests that the body has a need to prevent long actin filaments from circulating.
Actin filaments in the extracellular space might alter some of the local properties of the microenvironment. For example, long filaments could increase the viscosity of the extracellular fluid, potentially affecting the normal traffic ofcells and proteins into lymph. Alternatively, actin might interfere with other processes that occur in this compartment, such as clot formation. We have shown that actin filaments can affect the formation of a coarse fibrin clot by interfering with the lateral association of protofibrils into fibrin bundles. The addition of plasma gelsolin abrogates this effect by shortening actin filaments (32) , indicating that for some processes, the state ofactin assembly may be more important than the mere presence of actin.
Plasma gelsolin therefore appears to be important in severing actin filaments, and to play a secondary role in clearing actin monomers from the blood. The higher affinity of DBP for actin monomers indicates that plasma gelsolin will be left unbound if only a large amount ofG-actin is released from cells (23) . The DBP-actin complexes entering the circulation would be cleared quickly. The uncomplexed plasma gelsolin would then be free to sever actin filaments. These filaments might be released into the extracellular space, or found within dying cells where gelsolin can mediate the disassembly of the cytoskeleton (37) . Higher levels of DBP (6-10 MM) as compared with plasma gelsolin (1) (2) (3) uM) may be present to provide a high level of monomerbinding protein, thereby ensuring the presence of a maximal amount of free plasma gelsolin, which is capable of severing filaments.
These studies suggest that there is a system in plasma designed to depolymerize and clear actin from the circulation. The combination of plasma gelsolin and DBP appears to be organized in a way that allows for the rapid clearance of actin while maximizing the ability of plasma gelsolin to depolymerize actin filaments.
